Tapinit, Jovelyn .
HRN: 22-48-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2023
METRONIDAZOLE 500MG (TAB)
03/21/2023
03/28/2023
PO
500mg/tab
TID
S/P NSVD, Thickly Meconium Stained Amniotic Fluid
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes